Throughout the last three months, 15 analysts have evaluated Procter & Gamble (NYSE:PG), offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 6 | 7 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 3 | 0 | 0 |
2M Ago | 1 | 0 | 0 | 0 | 0 |
3M Ago | 1 | 5 | 3 | 0 | 0 |
Analysts have set 12-month price targets for Procter & Gamble, revealing an average target of $173.33, a high estimate of $190.00, and a low estimate of $159.00. Surpassing the previous average price target of $169.91, the current average has increased by 2.01%.
An in-depth analysis of recent analyst actions unveils how financial experts perceive Procter & Gamble. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Linda Bolton Weiser | DA Davidson | Maintains | Neutral | $159.00 | $159.00 |
Linda Bolton Weiser | DA Davidson | Announces | Neutral | $159.00 | - |
Lauren Lieberman | Barclays | Maintains | Equal-Weight | $163.00 | $163.00 |
Korinne Wolfmeyer | Piper Sandler | Announces | Neutral | $174.00 | - |
Andrea Teixeira | JP Morgan | Raises | Overweight | $186.00 | $179.00 |
Michael Pohn | DZ Bank | Announces | Buy | $190.00 | - |
Lauren Lieberman | Barclays | Lowers | Overweight | $163.00 | $174.00 |
Andrea Teixeira | JP Morgan | Lowers | Overweight | $179.00 | $181.00 |
Nik Modi | RBC Capital | Raises | Sector Perform | $164.00 | $157.00 |
Kaumil Gajrawala | Jefferies | Lowers | Hold | $175.00 | $182.00 |
Robert Moskow | TD Cowen | Announces | Buy | $189.00 | - |
Andrea Teixeira | JP Morgan | Raises | Overweight | $181.00 | $170.00 |
Mark Astrachan | Stifel | Raises | Hold | $161.00 | $157.00 |
Lauren Lieberman | Barclays | Raises | Overweight | $174.00 | $170.00 |
Robert Ottenstein | Evercore ISI Group | Raises | Outperform | $183.00 | $177.00 |
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Procter & Gamble's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Procter & Gamble analyst ratings.
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Negative Revenue Trend: Examining Procter & Gamble's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -0.1% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Procter & Gamble's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 14.91% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Procter & Gamble's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 6.2%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.53%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.67, Procter & Gamble adopts a prudent financial strategy, indicating a balanced approach to debt management.
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.